These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15322992)

  • 1. The implications of linking questions within the SG and TTO methods.
    Spencer A
    Health Econ; 2004 Aug; 13(8):807-18. PubMed ID: 15322992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H
    Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The standard gamble showed better construct validity than the time trade-off.
    Puhan MA; Schünemann HJ; Wong E; Griffith L; Guyatt GH
    J Clin Epidemiol; 2007 Oct; 60(10):1029-33. PubMed ID: 17884597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rating scale, standard gamble, and time trade-off for people with traumatic spinal cord injuries.
    Lin MR; Hwang HF; Chung KP; Huang C; Chen CY
    Phys Ther; 2006 Mar; 86(3):337-44. PubMed ID: 16506870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correcting biases in standard gamble and time tradeoff utilities.
    van Osch SM; Wakker PP; van den Hout WB; Stiggelbout AM
    Med Decis Making; 2004; 24(5):511-7. PubMed ID: 15359000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility assessment among patients of primary angle closure/glaucoma in China: a preliminary study.
    Sun X; Zhang S; Wang N; Liang Y; Wang L; Fan S; Sun L
    Br J Ophthalmol; 2009 Jul; 93(7):871-4. PubMed ID: 19208679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TTO method and procedural invariance.
    Spencer A
    Health Econ; 2003 Aug; 12(8):655-68. PubMed ID: 12898663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of health and vision utilities in low vision patients.
    Malkin AG; Goldstein JE; Massof RW
    Optom Vis Sci; 2012 Mar; 89(3):288-95. PubMed ID: 22227913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-method approach to measuring health-state valuations.
    Salomon JA; Murray CJ
    Health Econ; 2004 Mar; 13(3):281-90. PubMed ID: 14981652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chained time trade-off and standard gamble methods. Applications in oesophageal cancer.
    McNamee P; Glendinning S; Shenfine J; Steen N; Griffin SM; Bond J
    Eur J Health Econ; 2004 Feb; 5(1):81-6. PubMed ID: 15452769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating preference scores in conventional and home nocturnal hemodialysis patients.
    McFarlane PA; Pierratos A; Bayoumi AM; Redelmeier DA
    Clin J Am Soc Nephrol; 2007 May; 2(3):477-83. PubMed ID: 17699454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of subjective expectations about length and quality of life on time trade-off answers.
    van Nooten F; Brouwer W
    Health Econ; 2004 Aug; 13(8):819-23. PubMed ID: 15322993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement.
    Attema AE; Brouwer WB
    Health Econ; 2008 Jul; 17(7):877-85. PubMed ID: 18074409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life (HRQL) scores reported from parents and their children with chronic illness differed depending on utility elicitation method.
    Sung L; Young NL; Greenberg ML; McLimont M; Samanta T; Wong J; Rubenstein J; Ingber S; Doyle JJ; Feldman BM
    J Clin Epidemiol; 2004 Nov; 57(11):1161-6. PubMed ID: 15567632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of 3 valuation methods for temporary health states in patients treated with oral anticoagulants.
    Locadia M; Stalmeier PF; Oort FJ; Prins MH; Sprangers MA; Bossuyt PM
    Med Decis Making; 2004; 24(6):625-33. PubMed ID: 15534343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of subjective life expectancy on health state valuations using a 10 year TTO.
    van Nooten FE; Koolman X; Brouwer WB
    Health Econ; 2009 May; 18(5):549-58. PubMed ID: 18702082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health values of patients with chronic hepatitis C infection.
    Sherman KE; Sherman SN; Chenier T; Tsevat J
    Arch Intern Med; 2004 Nov; 164(21):2377-82. PubMed ID: 15557419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The construction of standard gamble utilities.
    van Osch SM; Stiggelbout AM
    Health Econ; 2008 Jan; 17(1):31-40. PubMed ID: 17410521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis.
    Witney AG; Treharne GJ; Tavakoli M; Lyons AC; Vincent K; Scott DL; Kitas GD
    Rheumatology (Oxford); 2006 Aug; 45(8):975-81. PubMed ID: 16461437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.